Navigation Links
Whole body MRI is highly accurate in the early detection of breast cancer metastases
Date:5/5/2010

Whole body magnetic resonance imaging (MRI) should be the imaging modality of choice for the detection of breast cancer metastases (when the cancer has spread beyond the breast) as it is highly accurate and can detect bone metastases while a patient is still asymptomatic (shows no symptoms), according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Whole body MRI is a noninvasive medical test that helps physicians diagnose and treat breast cancer. Breast cancer cells commonly spread to the bones, lungs, liver, or brain. Metastatic breast cancer tumors may be found before or at the same time as the primary tumor, or months and even years later.

"It is important that we detect metastases early in order to ensure the patient is getting the appropriate treatment. This study shows that whole body MRI can accomplish this task and is ready to be used for this indication," said Joshita Singh, MD, lead author of the study.

Besides MRI, other imaging modalities commonly used to detect breast cancer metastases include positron emission tomography computed tomography (PET/CT), chest X-rays, bone scans, and ultrasound of the abdomen and pelvis.

The study, performed at Deenanath Mangeshkar Hospital and Research Center in Pune, India, included 99 patients with known breast cancer who were evaluated for metastases using whole body MRI. "Of the 99 patients, MRI accurately revealed that 47 patients were positive for metastases while 52 were negative. Of those patients who were positive for metastases, whole body MRI frequently detected bone metastases earlier when the patient was still asymptomatic," said Singh.

"As our study suggests, whole body MRI is an effective tool for the detection of metastases and unlike other procedures commonly used in this role, it emits no radiation. We highly recommend that whole body MRI be the imaging modality of choice for the detection of metastases in patients with breast cancer," she said.


'/>"/>

Contact: Heather Curry
hcurry@acr-arrs.org
703-390-9822
American College of Radiology / American Roentgen Ray Society
Source:Eurekalert

Related medicine news :

1. Patients whole genome reveals risk of diseases and adverse drug responses
2. Organic Wholesale Club Brings Wholesale Club Concept to Large Organic and Natural E-commerce Site
3. MMAR Medical Expands Wholesale Offering with Cybertech Distribution Deal
4. Whole Grains Take a Bite Out of Type 2 Diabetes Risk
5. VIDEO from Medialink and Juice Products Association: Teens Who Drink Juice Have Healthier Diets, Eat More Whole Fruit
6. Chlorella: A Green Whole Food That Can Help Improve the American Diet
7. Thomas E. Mower Meets With Dalai Lama; Receives Prestigious Champion Award from Whole Child International
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. US21, Inc. is Granted a Wholesale Distributor Permit from the Commonwealth of Virginia Board of Pharmacy
10. American Wholesalers Underwriting Ltd Adds Environmental Protection to Wholesalers Insurance Program, WIP(R)
11. Whole Foods Market(R) Sets Up Haitian Earthquake Relief Drive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: